Human innate immunosenescence: causes and consequences for immunity in old age

Trends in Immunology

Volumn 30, Issue 7, 2009, Pages 325-333

  Panda, Alexander ^a   Arjona, Alvaro ^a   Sapey, Elizabeth ^b   Bai, Fengwei ^a   Fikrig, Erol ^a   Montgomery, Ruth R ^a   Lord, Janet M ^b   Shaw, Albert C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; AGE DISTRIBUTION; AGING; CELL KILLING; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNOSENESCENCE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NEUTROPHIL; PHAGOCYTOSIS; REVIEW; VACCINATION; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; AGING; BASOPHILS; CYTOKINES; DENDRITIC CELLS; EOSINOPHILS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MACROPHAGES; NATURAL KILLER T-CELLS; NEUTROPHILS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 67649397909     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2009.05.004     Document Type: Review

References (112)

1. Auffray C., et al. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27 (2009) 669-692
2. Sebastian C., et al. MacrophAging: a cellular and molecular review. Immunobiology 210 (2005) 121-126
3. Fietta A., et al. Influence of aging on some specific and nonspecific mechanisms of the host defense system in 146 healthy subjects. Gerontology 40 (1994) 237-245
4. Ogawa T., et al. Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells. B cells and macrophages. Mech. Ageing Dev. 117 (2000) 57-68
5. Kawai T., and Akira S. TLR signaling. Semin. Immunol. 19 (2007) 24-32
6. Clark J.A., and Peterson T.C. Cytokine production and aging: overproduction of IL-8 in elderly males in response to lipopolysaccharide. Mech. Ageing Dev. 77 (1994) 127-139
7. Delpedro A.D., et al. Signal transduction in LPS-activated aged and young monocytes. J. Interferon Cytokine Res. 18 (1998) 429-437
8. Mariani E., et al. RANTES and MIP-1alpha production by T lymphocytes, monocytes and NK cells from nonagenarian subjects. Exp. Gerontol. 37 (2002) 219-226
9. Gon Y., et al. Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin. Exp. Immunol. 106 (1996) 120-126
10. van Duin D., and Shaw A.C. Toll-like receptors in older adults. J. Am. Geriatr. Soc. 55 (2007) 1438-1444
11. Ligthart G.J., et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech. Ageing Dev. 28 (1984) 47-55
12. van Duin D., et al. Age-associated defect in human TLR-1/2 function. J. Immunol. 178 (2007) 970-975
13. van Duin D., et al. Prevaccine determination of the expression of costimulatory b7 molecules in activated monocytes predicts influenza vaccine responses in young and older adults. J. Infect. Dis. 195 (2007) 1590-1597
14. Kong K.F., et al. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J. Virol. 82 (2008) 7613-7623
15. van den Biggelaar A.H.J., et al. Impaired innate immunity predicts frailty in old age. The Leiden 85-plus study. Exp. Gerontol. 39 (2004) 1407-1414
16. Dilger R.N., and Johnson R.W. Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J. Leukoc. Biol. 84 (2008) 932-939
17. Comin F., et al. Ageing and Toll-like receptor expression by innate immune cells in chronic human schistosomiasis. Clin. Exp. Immunol. 149 (2007) 274-284
18. Fagiolo U., et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23 (1993) 2375-2378
19. Franceschi C., et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 128 (2007) 92-105
20. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 51 (2000) 245-270
21. Forsey R.J., et al. Plasma cytokine profiles in elderly humans. Mech. Ageing Dev. 124 (2003) 487-493
22. Giuliani N., et al. Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp. Gerontol. 36 (2001) 547-557
23. Beharka A.A., et al. Interleukin-6 production does not increase with age. J. Gerontol. A Biol. Sci. Med. Sci. 56 (2001) B81-B88
24. Barbieri M., et al. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am. J. Physiol. Endocrinol. Metab. 284 (2003) E481-E487
25. Cohen H.J., et al. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am. J. Med. 114 (2003) 180-187
26. Ferrucci L., et al. Serum IL-6 level and the development of disability in older persons. J. Am. Geriatr. Soc. 47 (1999) 639-646
27. Leng S.X., et al. Inflammation and frailty in older women. J. Am. Geriatr. Soc. 55 (2007) 864-871
28. Fried L.P., et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci. 56 (2001) M146-M156
29. Di Bona D., et al. Effect of interleukin-6 polymorphisms on human longevity: a systematic review and meta-analysis. Ageing Res. Rev. 8 (2009) 36-42
30. Opal S.M., et al. The immunopathogenesis of sepsis in elderly patients. Clin. Infect. Dis. 41 Suppl 7 (2005) S504-S512
31. Maggio M., et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 575-584
32. Gabriel P., et al. Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Exp. Gerontol. 37 (2002) 235-247
33. Coppe J.P., et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6 (2008) 2853-2868
34. Stout R.D., and Suttles J. Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol. Rev. 205 (2005) 60-71
35. Straub, R.H. and Mocchegiani, E. (eds) (2004) The Neuroendocrine Immune Network in Ageing (Neuroimmune Biology, Vol. 4), Elsevier
36. Lago R., et al. Leptin beyond body weight regulation-current concepts concerning its role in immune function and inflammation. Cell. Immunol. 252 (2008) 139-145
37. Padgett D.A., and Loria R.M. Endocrine regulation of murine macrophage function: effects of dehydroepiandrosterone, androstenediol, and androstenetriol. J. Neuroimmunol. 84 (1998) 61-68
38. Vasto S., et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 128 (2007) 83-91
39. Yamashita N., et al. Effects of aging on the in vitro response of human lymphocytes to interleukin-2. Jpn. J. Med. 23 (1984) 211-215
40. Krishnaraj R. Immunosenescence of human NK cells: effects on tumor target recognition, lethal hit and interferon sensitivity. Immunol. Lett. 34 (1992) 79-84
41. Borrego F., et al. NK phenotypic markers and IL2 response in NK cells from elderly people. Exp. Gerontol. 34 (1999) 253-265
42. Vitale M., et al. The impairment of natural killer function in the healthy aged is due to a postbinding deficient mechanism. Cell. Immunol. 145 (1992) 1-10
43. Sansoni P., et al. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood 82 (1993) 2767-2773
44. Thompson J.S., et al. The immune status of healthy centenarians. J. Am. Geriatr. Soc. 32 (1984) 274-281
45. Miyaji C., et al. Functional alteration of granulocytes, NK cells, and natural killer T cells in centenarians. Hum. Immunol. 61 (2000) 908-916
46. Facchini A., et al. Increased number of circulating Leu 11+ (CD 16) large granular lymphocytes and decreased NK activity during human ageing. Clin. Exp. Immunol. 68 (1987) 340-347
47. Mariani E., et al. Age-associated changes in CD8+ and CD16+ cell reactivity: clonal analysis. Clin. Exp. Immunol. 81 (1990) 479-484
48. Ogata K., et al. Natural killer cells in the late decades of human life. Clin. Immunol. Immunopathol. 84 (1997) 269-275
49. Kutza J., and Murasko D.M. Age-associated decline in IL-2 and IL-12 induction of LAK cell activity of human PBMC samples. Mech. Ageing Dev. 90 (1996) 209-222
50. Mariani E., et al. Age-dependent decreases of NK cell phosphoinositide turnover during spontaneous but not Fc-mediated cytolytic activity. Int. Immunol. 10 (1998) 981-989
51. Edwards D.L., and Avis F.P. Antibody-dependent cellular cytotoxicity effector cell capability among normal individuals. J. Immunol. 123 (1979) 1887-1893
52. Fernandes G., and Gupta S. Natural killing and antibody-dependent cytotoxicity by lymphocyte subpopulations in young and aging humans. J. Clin. Immunol. 1 (1981) 141-148
53. Krishnaraj R., and Bhooma T. Cytokine sensitivity of human NK cells during immunosenescence. 2. IL2-induced interferon gamma secretion. Immunol. Lett. 50 (1996) 59-63
54. Mariani E., et al. Chemokine production by natural killer cells from nonagenarians. Eur. J. Immunol. 32 (2002) 1524-1529
55. Ogata K., et al. Association between natural killer cell activity and infection in immunologically normal elderly people. Clin. Exp. Immunol. 124 (2001) 392-397
56. Mariani E., et al. Effect of zinc supplementation on plasma IL-6 and MCP-1 production and NK cell function in healthy elderly: interactive influence of +647 MT1a and -174 IL-6 polymorphic alleles. Exp. Gerontol. 43 (2008) 462-471
57. Mocchegiani E., et al. Metallothioneins/PARP-1/IL-6 interplay on natural killer cell activity in elderly: parallelism with nonagenarians and old infected humans. Effect of zinc supply. Mech. Ageing Dev. 124 (2003) 459-468
58. Bendelac A., et al. The biology of NKT cells. Annu. Rev. Immunol. 25 (2007) 297-336
59. DelaRosa O., et al. Valpha24+ NKT cells are decreased in elderly humans. Exp. Gerontol. 37 (2002) 213-217
60. Jing Y., et al. Aging is associated with a rapid decline in frequency, alterations in subset composition, and enhanced Th2 response in CD1d-restricted NKT cells from human peripheral blood. Exp. Gerontol. 42 (2007) 719-732
61. Peralbo E., et al. Decreased frequency and proliferative response of invariant Valpha24Vbeta11 natural killer T (iNKT) cells in healthy elderly. Biogerontology 7 (2006) 483-492
62. Tarazona R., et al. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 121 (2000) 77-88
63. Peralbo E., et al. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing. Exp. Gerontol. 42 (2007) 703-708
64. Lemster B.H., et al. Induction of CD56 and TCR-independent activation of T cells with aging. J. Immunol. 180 (2008) 1979-1990
65. Abedin S., et al. Diversity of NKR expression in aging T cells and in T cells of the aged: the new frontier into the exploration of protective immunity in the elderly. Exp. Gerontol. 40 (2005) 537-548
66. Li G., et al. Epigenetic mechanisms of age-dependent KIR2DL4 expression in T cells. J. Leukoc. Biol. 84 (2008) 824-834
67. Laupland K.B., et al. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J. Infect. Dis. 187 (2003) 1452-1459
68. Schneider E.L. Infectious diseases in the elderly. Ann. Intern. Med. 98 (1983) 395-400
69. Edwards S.W., and Hallett M.B. Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today 18 (1997) 320-324
70. Raza K., et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res. Ther. 7 (2005) R784-R795
71. Mathur S.K., et al. Age-related changes in eosinophil function in human subjects. Chest 133 (2008) 412-419
72. Schwarzenbach H.R., et al. Skin reactivity, basophil degranulation and IgE levels in ageing. Clin. Allergy 12 (1982) 465-473
73. Marone G., et al. Human basophil releasability. I. Age-related changes in basophil releasability. J. Allergy Clin. Immunol. 77 (1986) 377-383
74. Sokol C.L., et al. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat. Immunol. 9 (2008) 310-318
75. Denzel A., et al. Basophils enhance immunological memory responses. Nat. Immunol. 9 (2008) 733-742
76. Fortin C.F., et al. Aging and neutrophils: there is still much to do. Rejuvenation Res. 11 (2008) 873-882
77. Lord J.M., et al. Neutrophil ageing and immunesenescence. Mech. Ageing Dev. 122 (2001) 1521-1535
78. Tortorella C., et al. Age-related impairment of GM-CSF-induced signalling in neutrophils: role of SHP-1 and SOCS proteins. Ageing Res. Rev. 6 (2007) 81-93
79. Schroder A.K., and Rink L. Neutrophil immunity of the elderly. Mech. Ageing Dev. 124 (2003) 419-425
80. Lord J.M., et al. Synergistic effects of ageing and stress on neutrophil function. In: Fulop T., et al. (Ed). Handbook of Immunosenescence (2009), Springer 475-498
81. Fortin C.F., et al. GM-CSF activates the Jak/STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals. Biogerontology 8 (2007) 173-187
82. Vandivier R.W., et al. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest 129 (2006) 1673-1682
83. Fortin C.F., et al. Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. FEBS Lett. 581 (2007) 1173-1178
84. Alvarez E., et al. Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peritoneal neutrophils. Clin. Exp. Immunol. 124 (2001) 95-102
85. Simons K., and Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1 (2000) 31-39
86. Fortin C.F., et al. Impairment of SHP-1 down-regulation in the lipid rafts of human neutrophils under GM-CSF stimulation contributes to their age-related, altered functions. J. Leukoc. Biol. 79 (2006) 1061-1072
87. Fulop T., et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 3 (2004) 217-226
88. Tortorella C., et al. Role of phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in granulocyte macrophage-colony-stimulating factor failure to delay fas-induced neutrophil apoptosis in elderly humans. J. Gerontol. A Biol. Sci. Med. Sci. 61 (2006) 1111-1118
89. Biasi D., et al. Neutrophil migration, oxidative metabolism, and adhesion in elderly and young subjects. Inflammation 20 (1996) 673-681
90. Butcher S.K., et al. Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J. Leukoc. Biol. 70 (2001) 881-886
91. Wenisch C., et al. Effect of age on human neutrophil function. J. Leukoc. Biol. 67 (2000) 40-45
92. Egger G., et al. Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters. Intensive Care Med. 30 (2004) 331-334
93. Niwa Y., et al. Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: cross-sectional and longitudinal studies. Life Sci. 44 (1989) 1655-1664
94. Kadowaki N. The divergence and interplay between pDC and mDC in humans. Front. Biosci. 14 (2009) 808-817
95. Della Bella S., et al. Peripheral blood dendritic cells and monocytes are differently regulated in the elderly. Clin. Immunol. 122 (2007) 220-228
96. Shodell M., and Siegal F.P. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand. J. Immunol. 56 (2002) 518-521
97. Agrawal A., et al. Altered innate immune functioning of dendritic cells in elderly humans: a role of phosphoinositide 3-kinase-signaling pathway. J. Immunol. 178 (2007) 6912-6922
98. Steger M.M., et al. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin. Exp. Immunol. 105 (1996) 544-550
99. Lung T.L., et al. Unimpaired dendritic cells can be derived from monocytes in old age and can mobilize residual function in senescent T cells. Vaccine 18 (2000) 1606-1612
100. Bhushan M., et al. Tumour necrosis factor-alpha-induced migration of human Langerhans cells: the influence of ageing. Br. J. Dermatol. 146 (2002) 32-40
101. Bodineau A., et al. Do Langerhans cells behave similarly in elderly and younger patients with chronic periodontitis?. Arch Oral Biol. 52 (2007) 189-194
102. Bodineau A., et al. Increase of gingival matured dendritic cells number in elderly patients with chronic periodontitis. Arch. Oral Biol. 54 (2009) 12-16
103. Zavala W.D., and Cavicchia J.C. Deterioration of the Langerhans cell network of the human gingival epithelium with aging. Arch. Oral Biol. 51 (2006) 1150-1155
104. Szakal A.K., et al. Molecular interactions of FDCs with B cells in aging. Semin. Immunol. 14 (2002) 267-274
105. Dunn-Walters D.K., et al. Effects of age on antibody affinity maturation. Biochem. Soc. Trans. 31 (2003) 447-448
106. Frasca D., et al. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J. Immunol. 180 (2008) 5283-5290
107. Wikby A., et al. Changes in CD8 and CD4 lymphocyte subsets. T cell proliferation responses and non-survival in the very old: the Swedish longitudinal OCTO-immune study. Mech. Ageing Dev. 102 (1998) 187-198
108. Castle S.C., et al. Antigen presenting cell function is enhanced in healthy elderly. Mech. Ageing Dev. 107 (1999) 137-145
109. Pietschmann P., et al. Surface markers and transendothelial migration of dendritic cells from elderly subjects. Exp. Gerontol. 35 (2000) 213-224
110. Looney R.J., et al. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J. Infect. Dis. 185 (2002) 682-685
111. Agrawal A., et al. Increased reactivity of dendritic cells from aged subjects to self-antigen, the human DNA. J. Immunol. 182 (2009) 1138-1145
112. Fukao T., and Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol. 24 (2003) 358-363